CPE, a private equity firm, led a $130m round in MicroPort, a medical equipments manufacturer. Additional investors include CMP Cardio Investment, AUT-XVI Holdings, LBC Sunshine Healthcare, Gamnat, Gortune Artemis, Happy Soul, and CDG Group. "With about 10 years of committed development of its aortic valve business, MicroPort® CardioFlow has become an influential player in the field of heart valve in China and been favored by the capital market. This round of fundraising will bring in more resources for the development of the company in research and development, manufacturing, market expansion, and the enhancement of its market competitiveness. We have every confidence that we will maintain rapid development in the niche market of medical devices for valvular heart diseases, so as to provide more patients with high-quality and accessible integrated therapeutic solutions to valvular diseases,” Qiyi Luo, MicroPort CTO.